1 |
Torres-Ruiz J, Lomelín-Gascón J, Lira Luna J, Vargas-Castro AS, Pérez-Fragoso A, Nuñez-Aguirre M, Alcalá-Carmona B, Absalón-Aguilar A, Balderas-Miranda JT, Maravillas-Montero JL, Mejía-Domínguez NR, Núñez-Álvarez C, Llorente L, Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, Juárez-Vega G, Meza-Sánchez D, Rull-Gabayet M, Martínez-Juárez LA, Morales L, López-López LN, Negrete-Trujillo JA, Falcón-Lezama JA, Valdez-Vázquez RR, Gallardo-Rincón H, Tapia-Conyer R, Gómez-Martín D. Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study. Infect Dis (Lond) 2023;55:243-54. [PMID: 36637466 DOI: 10.1080/23744235.2022.2158217] [Reference Citation Analysis]
|
2 |
Nobili A, D'Avanzo B, Tettamanti M, Galbussera AA, Remuzzi G, Fortino I, Leoni O, Harari S, Mannucci PM. Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact. Intern Emerg Med 2023. [PMID: 36944811 DOI: 10.1007/s11739-023-03228-5] [Reference Citation Analysis]
|
3 |
Herrero-Montes M, Fernández-de-Las-Peñas C, Ferrer-Pargada D, Izquierdo-Cuervo S, Abascal-Bolado B, Valera-Calero JA, Paras-Bravo P. Association of Kinesiophobia with Catastrophism and Sensitization-Associated Symptoms in COVID-19 Survivors with Post-COVID Pain. Diagnostics (Basel) 2023;13. [PMID: 36899992 DOI: 10.3390/diagnostics13050847] [Reference Citation Analysis]
|
4 |
Yan MZ, Yang M, Lai CL. Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management. Viruses 2023;15. [PMID: 36851746 DOI: 10.3390/v15020533] [Reference Citation Analysis]
|
5 |
Di Nicola M, Pepe M, Montanari S, Spera MC, Panaccione I, Simonetti A, Sani G. Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes. Eur Neuropsychopharmacol 2023;70:21-8. [PMID: 36808043 DOI: 10.1016/j.euroneuro.2023.02.006] [Reference Citation Analysis]
|
6 |
Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J Microbiol Immunol Infect 2023;56:1-9. [PMID: 36283919 DOI: 10.1016/j.jmii.2022.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
7 |
Lalwani M, Taksande AB. Pulmonary Function Test as a Diagnostic Tool for Post-COVID-19 Effects. Cureus 2023;15:e34751. [PMID: 36909025 DOI: 10.7759/cureus.34751] [Reference Citation Analysis]
|
8 |
Liao B, Deng YK, Zeng M, Liu Z. Long-term Consequences of COVID-19: Chemosensory Disorders. Curr Allergy Asthma Rep 2023;23:111-9. [PMID: 36574210 DOI: 10.1007/s11882-022-01062-x] [Reference Citation Analysis]
|
9 |
Zappacosta S, Cascarano A, Konrad M, Tanislav C, Kostev K. Association between COVID-19 and subsequent vascular events in primary care patients in Germany. Public Health 2022;213:107-13. [PMID: 36403399 DOI: 10.1016/j.puhe.2022.10.005] [Reference Citation Analysis]
|
10 |
Dove S, Turlington L, Elmendorf K, Mahachi K, Petersen C, Meyer D. Singing Voice Symptomatology Following Presumed SARS-CoV-2 Infection. J Voice 2022:S0892-1997(22)00364-2. [PMID: 36470824 DOI: 10.1016/j.jvoice.2022.11.012] [Reference Citation Analysis]
|
11 |
Fernández-de-Las-Peñas C, Nijs J, Neblett R, Polli A, Moens M, Goudman L, Shekhar Patil M, Knaggs RD, Pickering G, Arendt-Nielsen L. Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition. Biomedicines 2022;10:2562. [PMID: 36289827 DOI: 10.3390/biomedicines10102562] [Reference Citation Analysis]
|